4//SEC Filing
Harlow John B. Jr. 4
Accession 0001628280-25-055842
CIK 0001434868other
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 4:27 PM ET
Size
20.2 KB
Accession
0001628280-25-055842
Insider Transaction Report
Form 4
Harlow John B. Jr.
Chief Commercial Officer
Transactions
- Award
Common Stock
2025-12-04+424,536→ 424,536 total - Award
Stock Option (right to buy)
2025-12-04+380,000→ 380,000 totalExercise: $3.79Exp: 2035-12-04→ Common Stock (380,000 underlying)
Footnotes (1)
- [F1]Such award will vest over a four (4) year period as follows: 25% shall vest on the respective one year anniversary of the vesting commencement date of December 15, 2025 and the remainder shall vest in equal quarterly installments over the three (3) year period thereafter.
Documents
Issuer
Esperion Therapeutics, Inc.
CIK 0001434868
Entity typeother
Related Parties
1- filerCIK 0002095554
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 4:27 PM ET
- Size
- 20.2 KB